[1]
“ACUTE RENAL FAILURE DUE TO RHABDOMYOLYSIS TREATED WITH OLMESARTAN ”, Int. Res. J. Pharm., vol. 10, no. 5, pp. 49–55, May 2019, Accessed: Jul. 17, 2026. [Online]. Available: https://irjponline.org/index.php/irjp/article/view/446